Aspen Pharmacare in talks for Merck API facility in the Netherlands

Aspen PharmaCare (Durban, South Africa) is in discussions with Merck Sharp Dohme (MSD; Darmstadt, Germany) regarding a possible acquisition of a Merck active pharmaceutical ingredient (API) facility in the Netherlands and a related portfolio of pharmaceutical finished dose form products, Aspen announced today. No further details were immediately...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers